Nicole El-Turk1,2, Michael S H Chou1,2, Natasha C H Ting1,2, Afaf Girgis2,3, Shalini K Vinod2,3,4, Victoria Bray3,4, Claudia C Dobler1,2,5. 1. Department of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW, Australia. 2. South Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia. 3. Centre for Oncology Education and Research Translation (CONCERT), Ingham Institute for Applied Medical Research, Sydney, NSW, Australia. 4. Cancer Therapy Centre, Liverpool Hospital, Sydney, NSW, Australia. 5. Institute for Evidence-Based Healthcare, Bond University and Gold Coast University Hospital, Gold Coast, QLD, Australia.
Abstract
INTRODUCTION: Patients' burden from lung cancer treatment is not well researched, but this understanding can facilitate a patient-centred treatment approach. Current models of treatment burden suggest it is influenced by a patient's perception of their disease and treatment and their capacity to do the work required to treat their disease. METHODS: Sixteen patients and 1 carer who were undergoing or had completed conventional or stereotactic ablative radiotherapy, chemotherapy or immunotherapy for lung cancer in the last 6 months participated in a semi-structured interview. A treatment burden framework was used with three main themes: a) treatment work, b) consequences of treatment and c) psychosocial factors affecting treatment burden. RESULTS: The majority of patients did not feel unduly burdened by treatment tasks, despite having a large treatment-associated workload. Many saw treatment as a priority, causing them to restructure their life to accommodate for it. Patients wished that they would have been better informed about the lifestyle changes that they would have to make before treatment for lung cancer commenced and that the health service would provide services to assist them with this task. DISCUSSION: While there was a large burden associated with lung cancer treatment, patients felt motivated and equipped to manage the workload because the disease was considered severe and life-threatening, and the treatment was seen as beneficial. Before initiating treatment for lung cancer, patients should be informed about lifestyle changes they likely have to make and should be offered assistance.
INTRODUCTION:Patients' burden from lung cancer treatment is not well researched, but this understanding can facilitate a patient-centred treatment approach. Current models of treatment burden suggest it is influenced by a patient's perception of their disease and treatment and their capacity to do the work required to treat their disease. METHODS: Sixteen patients and 1 carer who were undergoing or had completed conventional or stereotactic ablative radiotherapy, chemotherapy or immunotherapy for lung cancer in the last 6 months participated in a semi-structured interview. A treatment burden framework was used with three main themes: a) treatment work, b) consequences of treatment and c) psychosocial factors affecting treatment burden. RESULTS: The majority of patients did not feel unduly burdened by treatment tasks, despite having a large treatment-associated workload. Many saw treatment as a priority, causing them to restructure their life to accommodate for it. Patients wished that they would have been better informed about the lifestyle changes that they would have to make before treatment for lung cancer commenced and that the health service would provide services to assist them with this task. DISCUSSION: While there was a large burden associated with lung cancer treatment, patients felt motivated and equipped to manage the workload because the disease was considered severe and life-threatening, and the treatment was seen as beneficial. Before initiating treatment for lung cancer, patients should be informed about lifestyle changes they likely have to make and should be offered assistance.
Authors: David T Eton; Tarig A Elraiyah; Kathleen J Yost; Jennifer L Ridgeway; Anna Johnson; Jason S Egginton; Rebecca J Mullan; Mohammad Hassan Murad; Patricia J Erwin; Victor M Montori Journal: Patient Relat Outcome Meas Date: 2013-06-05
Authors: Kasey R Boehmer; Michael R Gionfriddo; Rene Rodriguez-Gutierrez; Abd Moain Abu Dabrh; Aaron L Leppin; Ian Hargraves; Carl R May; Nathan D Shippee; Ana Castaneda-Guarderas; Claudia Zeballos Palacios; Pavithra Bora; Patricia Erwin; Victor M Montori Journal: BMC Fam Pract Date: 2016-09-01 Impact factor: 2.497
Authors: Carl R May; David T Eton; Kasey Boehmer; Katie Gallacher; Katherine Hunt; Sara MacDonald; Frances S Mair; Christine M May; Victor M Montori; Alison Richardson; Anne E Rogers; Nathan Shippee Journal: BMC Health Serv Res Date: 2014-06-26 Impact factor: 2.655
Authors: Rosie J Goodburn; Marielle E P Philippens; Thierry L Lefebvre; Aly Khalifa; Tom Bruijnen; Joshua N Freedman; David E J Waddington; Eyesha Younus; Eric Aliotta; Gabriele Meliadò; Teo Stanescu; Wajiha Bano; Ali Fatemi-Ardekani; Andreas Wetscherek; Uwe Oelfke; Nico van den Berg; Ralph P Mason; Petra J van Houdt; James M Balter; Oliver J Gurney-Champion Journal: Magn Reson Med Date: 2022-09-21 Impact factor: 3.737